Junko Ishizaki Selected Research

Junko Ishizaki Research Topics

Disease

2	Insulin Resistance 01/2022 - 01/2011
2	Pain (Aches) 01/2018 - 08/2002
2	Neoplasms (Cancer) 12/2011 - 11/2009
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Diabetes Mellitus 01/2022
1	Dementia (Dementias) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Cognitive Dysfunction 01/2021
1	Leukemia 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Neutropenia 01/2017
1	Vomiting 01/2017
1	Olfaction Disorders (Cacosmia) 12/2011
1	Metabolic Diseases (Metabolic Disease) 01/2011
1	Obesity 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 01/2011
1	Hyperlipidemias (Hyperlipidemia) 01/2011
1	Fatty Liver 01/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2011
1	Wilms Tumor (Wilm's Tumor) 11/2009
1	Erythema 11/2009
1	Asthma (Bronchial Asthma) 01/2009
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Inflammation (Inflammations) 01/2009
1	Phlebitis 01/2009
1	Liver Failure 09/2007
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2006
1	Ascites 05/2004
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 11/2003

Drug/Important Bio-Agent (IBA)

3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2009
3	Pharmaceutical PreparationsIBA 01/2006 - 08/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
2	ApolipoproteinsIBA 01/2021 - 11/2003
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2017
2	SolutionsIBA 01/2018 - 08/2002
2	SteroidsIBA 01/2009 - 01/2009
1	AlbuminsIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	Apolipoprotein E4IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	AntiemeticsIBA 01/2017
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	geniposideIBA 01/2011
1	LipidsIBA 01/2011
1	GlycosidesIBA 01/2011
1	Nonesterified Fatty Acids (NEFA)IBA 01/2011
1	genipinIBA 01/2011
1	IridoidsIBA 01/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2009
1	HLA-A Antigens (HLA-A)IBA 11/2009
1	VaccinesIBA 11/2009
1	Peptides (Polypeptides)IBA 11/2009
1	Ointments (Pastes)IBA 01/2009
1	betamethasone sodium phosphate FDA LinkGeneric 01/2009
1	Epirubicin (Ellence)FDA LinkGeneric 01/2009
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2007
1	Carbon Tetrachloride (Tetrachloromethane)IBA 09/2007
1	Tolbutamide (Orinase)FDA LinkGeneric 01/2006
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2006
1	Chlorzoxazone FDA LinkGeneric 01/2006
1	Caffeine (No Doz)FDA LinkGeneric 01/2006
1	Transaminases (Aminotransferases)IBA 01/2006
1	Vitamin E FDA LinkGeneric 11/2003
1	alpha-Tocopherol FDA Link 11/2003
1	glycolic acid (glycolate)IBA 11/2003
1	Apolipoproteins B (ApoB)IBA 11/2003
1	Diclofenac (SR 38)FDA LinkGeneric 08/2002
1	Dacarbazine (DIC)FDA LinkGeneric 08/2002
1	Acetic Acid (Vinegar)FDA LinkGeneric 08/2002
1	A-factor (Streptomyces)IBA 08/2002
1	5-diazoimidazole-4-carboxamideIBA 08/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2003
2	Drug Therapy (Chemotherapy) 01/2017 - 12/2011
1	Drug Tapering 01/2018
1	Immunotherapy 11/2009
1	Adjuvant Chemotherapy 01/2009
1	Oral Administration 01/2006
1	Intravenous Administration 01/2006
1	Microspheres (Microsphere) 11/2003